Skip to the rundown
GetYourBrief Product · Retatrutide
Search

Product · in the news since February 24, 2026

Retatrutide news

Retatrutide appeared in 5 news events on GetYourBrief between February 24, 2026 and August 5, 2026, on the Healthcare desk. The latest: "White House denies Trump sought compassionate use of obesity drug" (June 23, 2026).

When was Retatrutide in the news?

News events naming Retatrutide per month (one per story, however many outlets carried it). Source: GetYourBrief's record of the outlets' reports. April 2026 and May 2026: the intake of reports was interrupted, so these months undercount.

The latest news about Retatrutide

  1. Aug 3 · Healthcare 933thedrive.com: “Eli Lilly to offer early access to next - gen obesity drug to some patients” 2
  2. Jun 23 · Healthcare White House denies Trump sought compassionate use of obesity drug 2
  3. Mar 19 · Healthcare Endpoints News: “Lilly’s triple-G lags Mounjaro on blood sugar lowering, first Phase 3 diabetes data suggest” 1

Which outlets cover Retatrutide most?

  1. Endpoints News 2

Counted over the latest 5 events; one per outlet per event. Source: the reports linked on each event.

Who appears in the news with Retatrutide?

  1. Eli Lilly 5
  2. Novo Nordisk 3
  3. Food and Drug Administration 2

Sources: the outlets' reports linked on this page; counts and times from GetYourBrief's record of those reports (methodology).